Advertisement

Topics

Escalier raises $19m to fund novel psoriasis pill

09:15 EDT 14 Mar 2018 | pharmaphorum

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline. The company, based in Nijmegen, is developing both oral and topical ROR?t drug candidates for psoriasis and oth...

Original Article: Escalier raises $19m to fund novel psoriasis pill

NEXT ARTICLE

More From BioPortfolio on "Escalier raises $19m to fund novel psoriasis pill"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...